Daiwa Health Development announces webinar with Dr. Fred Pescatore on August
29, exploring clinical uses of their patented RBAC
ingredient.
LOS
ANGELES, Aug. 7, 2024 /PRNewswire-PRWeb/ --
Daiwa Health Development, Inc. is excited to announce an
upcoming webinar featuring Dr. Fred Pescatore, a
renowned integrative medicine expert. The webinar will be held on
August 29, 2024, at 1
p.m. (PST) / 2 p.m. (MST) / 4 p.m.
(EST), and will delve into the clinical applications of RBAC
(Rice Bran Arabinoxylan Compound), Daiwa's
patented ingredient that is integral to one of their flagship
products.
As Daiwa Health Development celebrates over 30 years of
dedication to enhancing health through natural supplements, this
event underscores the company's ongoing commitment to innovation
and education. Founded by herbalist Yasuo
Ninomiya, Daiwa Health Development has consistently bridged
the gap between traditional Oriental medicine and modern scientific
research. This webinar represents a continuation of that tradition,
focusing on the clinical significance and benefits of RBAC.
RBAC, a proprietary ingredient developed by Daiwa, has been at
the forefront of their product line, known for its unique health
benefits. Dr. Fred Pescatore, an
acclaimed figure in integrative medicine, will provide insights
into how RBAC functions in a clinical setting, offering a valuable
perspective on its applications and effectiveness.
"Dr. Pescatore's expertise and reputation in the field of
integrative medicine make this webinar an exceptional opportunity
for health professionals and enthusiasts alike," said a
spokesperson for Daiwa Health Development. "We are thrilled to
bring this knowledge to our audience as part of our 20th
anniversary celebrations, reflecting our long-standing mission to
support healthier lifestyles through high-quality, natural
supplements."
Daiwa Health Development's commitment to excellence is evident
in every aspect of their operations. Their products are crafted in
small batches, ensuring the highest standards of purity and
efficacy. The company's dedication to sourcing ethical ingredients
and maintaining rigorous quality control continues to set them
apart in the health supplement industry.
RBAC, a proprietary immune-enhancing complex from Daiwa Health
Development, Inc., has been shown in clinical studies to enhance
the immune system by increasing the activity of white blood cells.
Scientific research indicates that the active ingredient in RBAC
can enhance Natural Killer (NK) cell function, increase the count
of T and B lymphocytes, and strengthen and increase macrophages and
cytokines. Derived from rice bran and modified by an enzyme from
Shiitake mushrooms, RBAC is an immune modulator known for its
safety and lack of harmful side effects. These statements have not
been evaluated by the Food and Drug Administration. This product is
not intended to diagnose, treat, cure, or prevent any disease.
For more information and to register for the webinar, visit the
Daiwa Health Development website [Daiwa Health Development website
__title__ Daiwa Health Development]. Don't miss this opportunity to
gain expert insights into RBAC and its clinical applications from
one of the leading voices in integrative medicine.
About Daiwa Health Development, Inc.
Daiwa Health Development, Inc. is committed to improving health
through high-quality, natural supplements. With over three decades
of experience, the company blends traditional Oriental medicine
with modern scientific advancements to deliver state-of-the-art
health products. Daiwa operates globally, maintaining a focus on
ethical practices and the highest standards of product quality.
Media Contact
Rachel Harris, Daiwa Health
Development, Inc., 888-888-8888, hcheatham@dhdusa.net,
https://www.dhdmed.com/
View original content to download
multimedia:https://www.prweb.com/releases/daiwa-health-development-inc-announces-webinar-with-dr-fred-pescatore-on-rbacs-clinical-applications-302217271.html
SOURCE Daiwa Health Development, Inc.